The Effect of Emotional Freedom Technique on Mental Well-Being and Stress Level in Pregnant Women

NCT ID: NCT06181903

Last Updated: 2024-07-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-28

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Emotional freedom technique will be applied to women with risky pregnancy. Emotional freedom technique group and control groups each consisted of 60 pregnant women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective In this experimental study, it was aimed to examine the effect of emotional freedom technique applied to women with risky pregnancy on mental well-being and stress levels.

Materials and Methods: This randomized controlled study will be conducted between February 2024 and August 2024 in Kahramanmaraş Necip Fazıl City Hospital Obstetrics and Gynecology Annex Building Obstetrics Outpatient Clinics with a total of 120 risk pregnant women (60 EFT, 60 control). EFT will be applied in the study. Women in the EFT group will receive EFT four times at one-week intervals. Pretest data will be obtained by filling out the Personal Information Form, Warwick-Edinburgh Mental Well-Being Scale (WEMWB), Prenatal Distress Scale - Revised Version before the Emotional Freedom Technique application. After the interventions, post-test data will be obtained by completing the Warwick-Edinburgh Mental Well-Being Scale (WEMWB), Prenatal Distress Scale - Revised Version. In addition, the Subjective Units of Experience (SUE) scale will be administered before and after each EFT intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnant at Risk

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Emotional freedom technique group

Emotional freedom technique will be applied to risky pregnant women in the emotional freedom technique group.

Group Type EXPERIMENTAL

Emotional freedom technique group

Intervention Type BEHAVIORAL

Control group

Control group

Pregnant women in the control group will not receive any intervention other than routine hospital care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Emotional freedom technique group

Control group

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

No Intervention

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older,
* Graduated from at least primary school
* Volunteering to participate in the research,
* Primiparous,
* Pregnant women who do not have conditions such as infection, wound, scar in the tapping areas.
* Pregnant women who meet any of the criteria in the Ministry of Health Risk Assessment Form for Pregnancy.

Exclusion Criteria

* Pregnant women who participated in EFT or other antenatal classes/programs during the study period.
* Those who did not want to continue participating in the study,
* Those with a psychological problem according to the pregnant women's statements.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kahramanmaras Sutcu Imam University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Esra KARATAŞ OKYAY

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eda SEVER

Role: STUDY_DIRECTOR

Kahramanmaras Sutcu Imam University

Esra GÜNEY, PhD

Role: STUDY_DIRECTOR

Inonu University

Esra KARATAŞ OKYAY, PhD

Role: PRINCIPAL_INVESTIGATOR

Kahramanmaras Sutcu Imam University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kahramanmaras Sutcu Imam University

Kahramanmaraş, Onikişubat, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Esra KARATAŞ OKYAY, PhD

Role: CONTACT

05432125225

Esra GÜNEY, PhD

Role: CONTACT

05432064063

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Esra KARATAŞ OKYAY, PhD

Role: primary

05432125225

References

Explore related publications, articles, or registry entries linked to this study.

Irmak Vural P, Aslan E. Emotional freedom techniques and breathing awareness to reduce childbirth fear: A randomized controlled study. Complement Ther Clin Pract. 2019 May;35:224-231. doi: 10.1016/j.ctcp.2019.02.011. Epub 2019 Feb 15.

Reference Type BACKGROUND
PMID: 31003663 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KSUESRAKARATASOKYAY005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.